LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
01 1LGM Pharma
02 2Dr. Reddy's Laboratories
03 1Jai Radhe Sales
04 2Moehs Iberica
05 1Faran Shimi Pharmaceutical
06 1Vamsi Labs
07 1HRV Global Life Sciences
08 1Zeon Pharma Industries India Pvt Ltd
09 1Apotex Pharmachem
10 1Aspire Lifesciences Pvt Ltd
11 1Asymchem Laboratories
12 2Aurobindo Pharma Limited
13 1CHEMO
14 1Cerata Pharmaceuticals
15 2Chromo Laboratories
16 1Cipla
17 1Darou Pakhsh Pharma Chem
18 2Divis Laboratories
19 1Hovione
20 1Ipca Laboratories
21 1KOLON Life Science, Inc
22 2MSN Laboratories
23 1Maithili Life Sciences
24 3Natco Pharma
25 1Nosch Labs Pvt
26 1Orchid Pharma
27 1Phalanx Labs
28 2Quimica Sintetica
29 1SM BIOMED
30 4SMS Pharmaceuticals
31 1Shandong Xinhua Pharmaceutical
32 1Smilax Laboratories Limited
33 1Srini Pharmaceuticals
34 1Sun Pharmaceutical Industries Limited
35 2Synergene Active Ingredients Pvt Ltd
36 1Therapiva
37 1Tianish Laboratories
38 1Viatris
01 1Canada
02 1China
03 36India
04 2Iran
05 1Malaysia
06 1Portugal
07 1South Korea
08 5Spain
09 3U.S.A
01 18Active
02 8Inactive
03 25Blank
01 10Valid
02 5Withdrawn by Holder
03 36Blank
01 1221MF10241
02 1223MF10048
03 1223MF10060
04 1228MF10195
05 47Blank
01 1WC-0017
02 1WC-0022
03 1WC-0026
04 1WC-0027
05 2WC-0030
06 1WC-0071
07 1WC-0118
08 1WC-0168
09 1WC-0317
10 1WC-0317A2
11 1WC-0347
12 1WC-0465
13 38Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16534
Submission : 2003-03-21
Status : Active
Type : II
Certificate Number : CEP 2023-022 - Rev 00
Issue Date : 2023-10-30
Type : Chemical
Substance Number : 1573
Status : Valid
NDC Package Code : 55111-060
Start Marketing Date : 2003-03-21
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-06-24
Pay. Date : 2013-06-19
DMF Number : 17352
Submission : 2004-04-29
Status : Active
Type : II
NDC Package Code : 52932-0727
Start Marketing Date : 2009-10-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : ASMF |
Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.
Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37551
Submission : 2022-09-30
Status : Active
Type : II
NDC Package Code : 55111-060
Start Marketing Date : 2003-03-21
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-11-22
Pay. Date : 2013-02-13
DMF Number : 24026
Submission : 2010-08-02
Status : Active
Type : II
NDC Package Code : 52932-0727
Start Marketing Date : 2009-10-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : ASMF |
We have 38 companies offering Sumatriptan Succinate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?